AS-99
AS-99 is a first-in-class, potent, and selective ASH1L histone methyltransferase inhibitor (IC50= 0.79 μM, Kd= 0.89 μM) with anti-leukemic activity. AS-99 blocks cell proliferation, induces apoptosis and differentiation, downregulates MLL fusion target genes, and reduces the leukemia burden in vivo[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; Histone Methyltransferase
Type
Reference compound
Related Pathways
Apoptosis; Epigenetics
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/as-99-1.html
Solubility
10 mM in DMSO
Smiles
O=C(C1CN(C)C1)NCC2=CC3=C(C=C2)C(C4=CC=CC(C(N)=S)=C4)=CN3C5CCN(S(=O)(C(F)(F)F)=O)CC5.[H]Cl
Molecular Formula
C27H31ClF3N5O3S2
Molecular Weight
630.14
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
ASH1L/KMT2H
Citation 01
Adv Sci (Weinh) . 2024 Dec;11 (45) :e2404756.|Nat Commun. 2025 May 20;16 (1) :4681.
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MEF2A (Myocyte Enhancer Factor 2A, ADCAD1, RSRFC4, RSRFC9) (MaxLight 490)
